VEGFA and neoplasm: The fact that VEGF was (until recently) thought to be a growth factor specific for endothelium and not widely expressed outside of tissue undergoing active angiogenesis (tumours, wounds, tissues that form part of the female reproductive tract) identified VEGF as a key molecular target for antiangiogenic therapy.